NASDAQ : IRIX

IRIDEX Corporation — Financial statements

Healthcare · Medical Devices · United States

Last price 0.7119 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 12.50M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

IRIDEX Corporation (IRIX) reported revenue of 51.57M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year February - January; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue51.57M52.67M48.67M51.87M56.97M53.90M
Cost of Revenue33.05M33.45M29.17M30.06M31.60M31.07M
Gross Profit18.53M19.23M19.50M21.81M25.37M22.83M
Selling, General & Admin17.54M18.13M22.36M24.98M25.73M23.50M
Research & Development3.76M3.67M5.45M6.83M7.17M6.87M
Operating Expenses21.31M21.80M27.80M31.81M32.91M30.36M
Operating Income-2.78M-2.57M-8.30M-10.01M-7.54M-7.53M
Other Non Operating Income (Expenses)-616.00K-1.81M-540.00K527.00K60.00K-152.00K
EBT Excluding Unusual Items-3.40M-4.38M-8.84M-9.48M-7.48M-7.68M
Other Unusual Items2.50M
Pretax Income-3.40M-4.38M-8.84M-9.48M-7.48M-5.18M
Income Tax Expense152.00K57.00K68.00K90.00K65.00K40.00K
Net Income-3.55M-4.44M-8.91M-9.57M-7.55M-5.22M
Net Income to Common-3.55M-4.44M-8.91M-9.57M-7.55M-5.22M
Shares Outstanding (Basic)17.24M16.93M16.44M16.13M15.94M15.42M
Shares Outstanding (Diluted)17.24M16.93M16.44M16.13M15.94M15.42M
EPS (Basic)-0.21-0.26-0.54-0.59-0.47-0.34
EPS (Diluted)-0.21-0.26-0.54-0.59-0.47-0.34
Free Cash Flow-2.00M-2.26M-7.30M-6.85M-9.80M8.00M
Free Cash Flow Per Share-0.12-0.13-0.44-0.42-0.610.52
Gross Margin35.92%36.50%40.07%42.04%44.53%42.36%
Operating Margin-5.39%-4.88%-17.06%-19.29%-13.24%-13.98%
Profit Margin-6.88%-8.42%-18.31%-18.45%-13.25%-9.69%
Free Cash Flow Margin-3.88%-4.29%-14.99%-13.21%-17.21%14.85%
EBITDA-2.60M-2.32M-7.99M-9.18M-7.22M-6.73M
EBITDA Margin-5.05%-4.40%-16.41%-17.70%-12.68%-12.48%
D&A For EBITDA175.00K251.00K314.00K828.00K320.00K803.00K
EBIT-2.78M-2.57M-8.30M-10.01M-7.54M-7.53M
EBIT Margin-5.39%-4.88%-17.06%-19.29%-13.24%-13.98%
Advertising Expenses17.00K20.00K200.00K400.00K200.00K

Balance sheet

Fiscal year February - January; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents4.68M6.03M2.39M7.03M13.92M23.85M
Cash & Short-Term Investments4.68M6.03M2.39M7.03M13.92M23.85M
Receivables7.09M9.54M8.39M9.65M9.77M9.72M
Inventory9.75M7.88M10.82M9.91M10.61M7.61M
Prepaid Expenses2.44M1.80M1.96M856.00K1.47M1.07M
Total Current Assets23.96M25.25M23.56M27.45M35.77M42.25M
Property, Plant & Equipment402.00K826.00K1.91M2.98M2.13M2.99M
Goodwill965.00K965.00K965.00K965.00K965.00K965.00K
Other Intangible Assets825.00K984.00K1.31M1.64M1.98M2.21M
Other Long-Term Assets1.11M1.12M1.39M1.40M1.46M271.00K
Total Assets27.26M29.15M29.14M34.44M42.29M48.69M
Accounts Payable6.81M5.50M7.59M4.73M3.87M3.40M
Accrued Expenses2.39M2.92M2.00M3.52M3.93M4.69M
Current Portion of Long-Term Debt1.73M
Current Portion of Leases141.00K699.00K1.09M995.00K1.04M927.00K
Current Income Taxes Payable31.00K150.00K100.00K65.00K73.00K
Current Unearned Revenue2.15M2.16M2.18M2.40M2.41M2.35M
Other Current Liabilities1.68M1.90M1.81M1.23M1.14M1.20M
Total Current Liabilities13.17M13.21M16.56M12.97M12.45M12.65M
Long-Term Debt3.79M3.73M1.00M
Long-Term Leases77.00K98.00K811.00K1.75M732.00K1.73M
Long-Term Unearned Revenue6.08M6.80M8.35M10.03M11.74M10.93M
Other Long-Term Liabilities496.00K387.00K314.00K164.00K132.00K83.00K
Total Liabilities23.62M24.23M27.04M24.91M25.06M25.39M
Common Stock174.00K174.00K174.00K172.00K169.00K168.00K
Additional Paid-In Capital91.71M91.21M89.88M88.44M86.80M85.25M
Retained Earnings-94.24M-92.45M-88.01M-79.04M-69.72M-62.17M
Comprehensive Income & Other-11.00K-14.00K51.00K-52.00K-24.00K45.00K
Total Common Equity-2.36M-1.08M2.10M9.52M17.23M23.30M
Shareholders' Equity3.64M4.92M2.10M9.52M17.23M23.30M
Total Liabilities & Equity27.26M29.15M29.14M34.44M42.29M48.69M
Total Debt4.01M4.53M4.64M2.75M1.77M2.66M
Net Cash (Debt)667.00K1.50M-2.26M4.29M12.15M21.20M
Net Cash Per Share0.040.09-0.140.270.761.37
Filing Date Shares Outstanding17.56M17.31M16.79M16.25M16.01M15.88M
Total Common Shares Outstanding17.45M17.31M16.64M16.25M15.99M15.88M
Working Capital10.79M12.04M7.00M14.48M23.31M29.61M
Book Value Per Share-0.14-0.060.130.591.081.47
Tangible Book Value-4.15M-3.03M-175.00K6.92M14.29M20.13M
Tangible Book Value Per Share-0.24-0.17-0.010.430.891.27
Machinery11.75M11.60M11.60M11.53M11.36M
Leasehold Improvements2.49M2.49M2.49M2.49M2.45M

Cash flow statement

Fiscal year February - January; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-3.55M-4.44M-8.91M-9.57M-7.55M-5.22M
Depreciation & Amortization1.25M1.27M1.15M1.76M1.22M1.71M
Other Amortization392.00K499.00K598.00K270.00K165.00K
Loss (Gain) From Sale of Assets3.00K
Stock-Based Compensation728.00K775.00K1.24M1.65M1.62M1.63M
Provision & Write-off of Bad Debts187.00K37.00K
Other Operating Activities823.00K2.16M-2.50M
Change in Accounts Receivable1.46M-1.66M776.00K-254.00K196.00K639.00K
Change in Inventory-2.14M2.12M-911.00K644.00K-3.02M268.00K
Change in Accounts Payable1.34M-1.95M2.49M641.00K1.09M1.62M
Change in Unearned Revenue-1.63M-1.56M-1.90M-1.72M868.00K12.06M
Change in Other Net Operating Assets-403.00K679.00K-1.82M-165.00K-4.29M-2.03M
Operating Cash Flow-1.73M-2.12M-7.29M-6.75M-9.52M8.22M
Capital Expenditures-270.00K-143.00K-13.00K-109.00K-286.00K-213.00K
Cash Acquisitions-5.34M
Investing Cash Flow-270.00K-143.00K-13.00K-109.00K-286.00K-5.56M
Long-Term Debt Issued4.00M3.37M
Long-Term Debt Repaid-3.96M-218.00K
Net Debt Issued (Repaid)39.00K3.15M
Issuance of Common Stock4.00K82.00K21.00K10.10M
Repurchase of Common Stock-100.00K-75.00K-58.00K-87.00K-94.00K-629.00K
Other Financing Activities-493.00K
Financing Cash Flow-100.00K5.96M2.60M-5.00K-73.00K9.47M
Foreign Exchange Rate Adjustments2.00K-65.00K46.00K-29.00K-52.00K99.00K
Net Cash Flow-2.10M3.64M-4.65M-6.89M-9.93M12.23M
Free Cash Flow-2.00M-2.26M-7.30M-6.85M-9.80M8.00M
Free Cash Flow Margin-3.88%-4.29%-14.99%-13.21%-17.21%14.85%
Free Cash Flow Per Share-0.12-0.13-0.44-0.42-0.610.52
Levered Free Cash Flow1.64M1.53M-1.21M-690.38K-5.74M-557.12K
Unlevered Free Cash Flow1.52M1.30M-1.54M-690.38K-5.74M-557.12K
Cash Income Tax Paid-22.00K15.00K53.00K73.00K15.00K
Change in Working Capital-1.38M-2.38M-1.37M-857.00K-5.16M12.56M

Ratios

Fiscal year February - January; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization12.67M20.11M27.78M45.66M32.14M96.94M
Enterprise Value12.01M25.32M28.83M40.57M18.26M74.26M
Last Close Price0.711.171.672.812.016.11
Forward PE56.8856.8856.8856.8856.88
PS Ratio0.250.380.570.880.561.80
PB Ratio3.504.0913.254.791.864.16
P/TBV Ratio6.602.254.82
P/FCF Ratio12.11
P/OCF Ratio11.80
PEG Ratio1.231.231.231.231.23
EV/Sales Ratio0.230.480.590.780.321.38
EV/FCF Ratio9.28
Debt / Equity Ratio1.100.922.210.290.100.11
Debt / FCF Ratio0.33
Net Debt / Equity Ratio-0.18-0.301.08-0.45-0.70-0.91
Net Debt / EBITDA Ratio0.260.65-0.280.471.683.15
Net Debt / FCF Ratio0.330.66-0.310.631.24-2.65
Asset Turnover1.751.811.531.351.251.41
Inventory Turnover3.633.582.812.933.474.66
Quick Ratio0.891.180.651.291.902.65
Current Ratio1.821.911.422.122.873.34
Return on Equity (ROE)-73.15%-126.43%-153.37%-71.54%-37.24%-25.70%
Return on Assets (ROA)-5.90%-5.51%-16.32%-16.30%-10.36%-12.28%
Return on Capital Employed (ROCE)-19.70%-16.10%-66.00%-46.60%-25.30%-20.90%
Earnings Yield-28.51%-22.06%-32.07%-20.96%-23.48%-5.39%
FCF Yield-15.70%-11.23%-26.27%-15.01%-30.51%8.26%
Buyback Yield / Dilution-3.35%-3.01%-1.93%-1.19%-3.35%-11.41%